Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$5.43 +0.09 (+1.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vanda Pharmaceuticals (VNDA) Current Taxes (2010 - 2011)

Vanda Pharmaceuticals (VNDA) posted Current Taxes of $2.1 million for Q3 2011, down 5.09% sequentially from $2.2 million in Q2 2011.

Analysis

Vanda Pharmaceuticals (VNDA) Current Taxes (2010 - 2011) Analysis & Trends

Vanda Pharmaceuticals has reported Current Taxes for 2 years, with the latest figure at $2.1 million in Q3 2011.

  • Quarterly Current Taxes changed N/A year-over-year to $2.1 million in Q3 2011, while the trailing twelve-month figure through Sep 2011 was $2.1 million (changed N/A YoY) and the FY2010 annual result came in at $2.3 million, changed N/A from the prior year.
  • Current Taxes declined to $2.1 million in Q3 2011 per VNDA's latest filing, from $2.2 million in the prior quarter.
  • Over five years, Current Taxes peaked at $2.3 million in Q4 2010 and troughed at $2.1 million in Q3 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 49.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 76.32 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Vanda Pharmaceuticals 327.03 Mn 157.00 Mn 46.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 2.11 Mn
Jun 30, 2011 2.22 Mn
Dec 31, 2010 2.27 Mn